Detection of residual aneuploid leukemic cells by 'continuous gating'

Cytometry

Volumn 36, Issue 1, 1999, Pages 71-76

  Kleine, Hans Dieter ^a   Zech, Immo ^a   Nowak, Ralf ^b   Oelschlägel, Uta ^b   Kundt, Günther ^a   Freund, Mathias ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Continuous Gating ; DNA; Flow cytometry; List mode data analysis; Minimal residual disease; Surface markers

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ANEUPLOIDY; ARTICLE; CASE REPORT; CELL ISOLATION; COMPUTER PROGRAM; DATA ANALYSIS; FLOW CYTOMETRY; HUMAN; LEUKEMIA CELL; MALE; PRIORITY JOURNAL;

ADULT; ANEUPLOIDY; ANTIGENS, CD19; ANTIGENS, CD34; BONE MARROW CELLS; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEPRILYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0033136513     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19990501)36:1<71::AID-CYTO9>3.0.CO;2-R     Document Type: Article

References (16)

1. Brisco J, Hughes E, Neoh SH, Sykes PJ, Bradstock K, Enno A, Szer J, McCaul K, Morley AA. Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood 1996;87: 5251-5256.
2. Arkesteijn GJ, Erpelinck SL, Martens AC, Hagemeijer A, Hagenbeek A. The use of FISH with chromosome-specific repetitive DNA probes for the follow-up of leukemia patients. Correlations and discrepancies with bone marrow cytology. Cancer Genet Cytogenet 1996;88:69-75.
3. Porwit-MacDonald A, Janossy G, Ivory K, Swirsky D, Peters R, Wheatley K, Walker H, Turker A, Goldstone AH, Burnett A. Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21). Blood 1996;87:1162-1169.
4. Macedo A, Orfao A, Ciudad J, Gonzalez M, Vidriales B, Lopez-Berges MC, Martinez A, Landolfi C, Canizo C, San-Miguel JF. Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease. Leukemia 1995;9:1896-1901.
5. Koller E, Karlic H, Krieger O, Mistrik M, Michlmayr G, Gadner H, Lutz D, Heinz R, Pittermann E. Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia. Ann Hematol 1995;70:75-78.
6. Flactif M, Zandecki M, Lai JL, Bernardl F, Obein V, Bauters F, Facon T. Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma. Leukemia 1995;9:2109-2114.
7. White DM, Crolla JA, Ross FM. Detection of minimal residual disease in childhood acute lymphoblastic leukaemia using fluorescence in-situ hybridization. Br J Haematol 1995;91:1019-1024.
8. Jensen IM, Kristensen JS, Thomsen M, Ellegaard J, Hokland P. Optimization of a method for simultaneous analysis of cell surface phenotype and cell cycle in human bone marrow and peripheral blood leukocytes by flow cytometry: the value of both internal and external standards. Anal Cell Pathol 1993;5:213-223.
9. Chucrallah AE, Stass SA, Huh YO, Albitar M, Kantarjian HM. Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes. Cancer 1995;76:985-991.
10. Carlo-Stella C, Mangoni L, Dotti GP, Rizzoli V. Techniques for detection of minimal residual disease. Leuk Lymphoma 1995;18: 75-80.
11. Hiddemann W, Harbott J, Ludwig WD, Ritter J, Nehmer A, Reiter A, Kolkmeyer A, Laing T, Riehm H. DNA aneuploidy in childhood acute lymphoblastic leukemia: relation to clinical determinants and prognosis within four consecutive BFM trials. Recent Results Cancer Res 1993;131:113-121.
12. Sievers EL, Loken MR. Detection of minimal residual disease in acute myelogenous leukemia. J Pediatr Hematol Oncol 1995;17:123-133.
13. Wong LS, Bateman WJ, Morris AG, Fraser IA. Detection of circulating tumour cells with the magnetic activated cell sorter. Br J Surg 1995;82:1333-1337.
14. Wörmann B, Safford M, Konemann S, Büchner T, Hiddemann W, Terstappen LW. Detection of aberrant antigen expression in acute myeloid leukemia by multiparameter flow cytometry. Recent Results Cancer Res 1993;131:185-196.
15. Farahat N, Lens D, Zomas A, Morilla R, Matutes E, Catovsky D. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors. Br J Haematol 1995;91:640-646.
16. Orfao A, Ciudad J, Gonzalez M, Lopez A, del-Mar-Abad M, Paz-Bouza JI, Cruz JJ, Gomez-Alonso A, San-Miguel JF. Flow cytometry in the diagnosis of cancer, Scand J Clin Lab Invest 1995;Suppl 221:145-152.